Logo
x

Search

Subscribe Now

FDA Approval

Johnson & Johnson MedTech Reports the US FDA’s Approval of VARIPULSE Pulsed Field Ablation Platform to Treat Atrial Fibrillation

Johnson & Johnson MedTech Reports the US FDA’s Approval of VARIPULSE Pulsed Field Ablation Platform to Treat Atrial Fibrillation

  • November 8, 2024
AstraZeneca and the US NIAID Report Results of Fasenra (benralizumab) in P-II Study for Hypereosinophilic Syndromes (HES)

AstraZeneca and the US NIAID Report Results of Fasenra (benralizumab) in P-II Study for Hypereosinophilic Syndromes (HES)

  • April 4, 2019
Clarus Therapeutics' Jatenzo (Testosterone Undecanoate Capsules for Oral Use) (CIII) Receives FDA'S Approval for Testosterone Replacement Therapy in Certain Adult Men

Clarus Therapeutics' Jatenzo (Testosterone Undecanoate Capsules for Oral Use) (CIII) Receives FDA'S Approval for Testosterone Repl...

  • March 27, 2019
Roche's Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) Receives FDA's Approval for Patients with HER2-Positive Breast Cancers

Roche's Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) Receives FDA's Approval for Patients with HER2-Positive Breast Canc...

  • March 1, 2019
Teva's ProAir Digihaler (Albuterol Sulfate 117 mcg) Inhalation Powder Receives FDA Approval for Asthma & COPD Patients Aged 4 Years or Older

Teva's ProAir Digihaler (Albuterol Sulfate 117 mcg) Inhalation Powder Receives FDA Approval for Asthma & COPD Patients Aged 4...

  • December 31, 2018
Merck's Keytruda (pembrolizumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma (HCC)

Merck's Keytruda (pembrolizumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma (HCC)

  • November 12, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.